You have made it through stimulation, the eggs are fertilised, an embryo is frozen and waiting, and the cycle now hinges on one number that has nothing to do with the embryo itself.
At a monitoring scan before transfer, the doctor measures the endometrium, the lining of the uterus the embryo must implant into.
A good measurement and the transfer proceeds. A borderline one and the cycle may be paused, which can feel like a sudden setback after everything else has gone well.
For many patients this is the first time the lining has been discussed in detail, and anxiety often grows quickly around it.
It helps to understand what the measurement means, what thresholds are actually used, and what interventions have real evidence behind them.
The endometrium is the inner lining of the uterus. Across a cycle it thickens under the influence of estrogen in preparation for implantation.
In IVF or frozen embryo transfer cycles, this process is controlled with medication rather than occurring naturally.
Thickness is measured by transvaginal ultrasound at the thickest point of the lining.
Clinicians also assess pattern, particularly the “triple-line” appearance, which often correlates with receptivity.
There is no absolute cut-off, but clinical practice tends to follow general thresholds.
Most clinics prefer a minimum of around 7 mm before proceeding with transfer.
The commonly observed ranges are:
This is not a strict pass/fail system.
Pregnancies do occur below 7 mm, and a thicker lining alone does not guarantee success.
The threshold reflects probability, not certainty.
Because frozen embryos can be stored, clinicians often choose to delay transfer if the lining is suboptimal rather than proceed under lower odds.
A persistently thin endometrium is not common, but when it occurs there are several possible causes.
Some of the more established causes include:
In some patients, no clear cause is identified and the lining remains naturally thinner than average.
Age, smoking history, and uterine health can also contribute to reduced endometrial responsiveness.
The first-line approach is usually optimization of estrogen exposure.
This may involve adjusting dose or changing delivery method.
Some patients respond better after changes in route or duration rather than increased complexity of treatment.
Other interventions are used with varying levels of evidence:
Emerging treatments such as platelet-rich plasma (PRP) are still considered experimental and not standard of care.
Where structural issues exist, medical therapy is not sufficient.
In cases of suspected scarring, hysteroscopy is the definitive diagnostic and therapeutic step.
In some cycles, the safest decision is to cancel or defer embryo transfer.
This allows time to reassess endometrial response and adjust treatment strategy without compromising an embryo.
Proceeding with a persistently thin lining may reduce implantation probability and waste a transfer opportunity.
In such cases, clinicians may investigate further rather than simply repeating the same protocol.
If two well-managed cycles fail to achieve adequate thickness, evaluation of the uterine cavity is often recommended.
Identifying the cause is more useful than repeatedly escalating medication without explanation.
A thin endometrial lining in a single cycle is not a definitive prognosis.
It is a modifiable finding in most cases.
Many patients respond to changes in estrogen delivery or timing.
Others improve after targeted investigation and treatment of underlying structural causes.
Only a small proportion remain persistently refractory despite appropriate intervention, and this group warrants deeper evaluation rather than repetition of the same approach.
If you are preparing for embryo transfer or have experienced a cycle cancellation due to thin lining, further assessment can help clarify the cause and improve future outcomes.
Clinics such as MMC IVF can evaluate endometrial response and tailor treatment protocols based on individual uterine behaviour rather than fixed regimens.
Schedule a consultation with our expert team at MMC IVF. We are here to provide personalized care and support.
MMCIVF and Zivanza Wellness are trademarks and tradenames owned by MUrgency Inc., USA.
Services listed on the MMCIVF.com website are available in each Country we provide services in through MMCIVF Affiliated Clinics licensed, regulated and supervised by the Competent Authorities in the respective Country and based on the applicable laws, rules and regulations in the respective Country / Jurisdiction.
MMCIVF operates Clinics in each Country as aforesaid above under the laws, rules and regulations of the respective Country. All patients / prospective patients / consultees / prospective consultees and / or anyone interacting with MMCIVF Clinics and / or MMCIVF Country Directors and / or MMCIVF Country Doctors and / or MMCIVF Country Nurses and / or MMCIVF Country Staff and / or MMCIVF Country Agents are expected to be fully compliant with the laws, rules and regulations in the respective Country and of any other jurisdiction they (the patients / prospective patients / consultees / prospective consultees and / or anyone interacting with MMCIVF Country and / or MMCIVF Country Directors and / or MMCIVF Country Doctors and / or MMCIVF Country Nurses and / or MMCIVF Country Staff and / or MMCIVF Country Agents) are subject to. MMCIVF Country / MMCIVF Country Directors / MMCIVF Country Doctors / MMCIVF Country Nurses / MMCIVF Country Staff / MMCIVF Country Agents cannot and will not take any responsibility and / or liability for compliance or non-compliance of any law, rule or regulation outside the respective Country where treatment is sought and provided which is solely the responsibility of the patients / prospective patients / consultees / prospective consultees and / or anyone interacting with MMCIVF Country and / or MMCIVF Country Directors and / or MMCIVF Country Doctors and / or MMCIVF Country Nurses and / or MMCIVF Country Staff and / or MMCIVF Country Agents.
Further, MMCIVF Country and / or MMCIVF Country Directors and / or MMCIVF Country Doctors and / or MMCIVF Country Nurses and / or MMCIVF Country Staff and / or MMCIVF Country Agents will not solicit and / or support any family balancing and / or sex determination and / or any prohibited medical procedure in India and / or any prohibited medical treatment in India to Indian Citizens / Residents (whether in India or outside India) strictly following this as MMCIVF Country policy recognizing and respecting applicable Indian Laws, Rules, and Regulations. All Indian Citizens / Residents are advised to ensure that they fully comply with the applicable Indian Laws, Rules, and Regulations while reaching out / interacting / communicating / consulting / taking treatment with MMCIVF Country. MMCIVF Country shall not take any responsibility whatsoever for any violation of any applicable Indian Laws, Rules, and Regulations by any Indian Citizen / Resident while reaching out / interacting / communicating / consulting / taking treatment with MMCIVF Country which sole responsibility shall vest with such Indian Citizens / Residents reaching out / interacting / communicating / consulting / taking treatment with MMCIVF Country. In case any individual / agency / firm / company reaches out to any Indian Citizen / Resident for and on behalf of MMCIVF Country for any family balancing and / or sex determination and / or any prohibited medical procedure in India and / or any prohibited medical treatment in India, please be known that we have not authorized any staff member / individual / agency / firm / company to reach out to Indian Citizens / Residents (whether in India or outside India) to offer and / or support any family balancing and / or sex determination and / or any prohibited medical procedure in India and / or any prohibited medical treatment in India. If you are aware of any such reach outs and / communication, please inform MMCIVF Country at info@mmcivf.ae immediately so that we can take remedial measures against such reach outs claiming to represent MMCIVF Country.
Further, MMCIVF in each Country operates independently and separately from other MMCIVF Clinics in Other Countries.
NOTE: Please read Country as respective Country – USA, Kenya, Georgia, Tanzania and United Arab Emirates as appropriate, relevant and applicable.